• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR CP RUBELLA G (RUB G) ASSAY; RUBELLA G IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR CP RUBELLA G (RUB G) ASSAY; RUBELLA G IMMUNOASSAY Back to Search Results
Model Number N/A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/13/2017
Event Type  malfunction  
Manufacturer Narrative
A siemens customer service engineer (cse) was sent to the customer site for system inspection.The cse replaced the base pump, reagent diluter, and reagent syringe valve while troubleshooting, and several samples were run with expected results.The customer has observed additional sample comparison results not matching when run in duplicate (actual results not provided).Siemens is investigating.
 
Event Description
A false positive advia centaur cp rubella g (rub g) result was obtained for a patient sample.The patient sample was sent to a reference laboratory (npl) and the rubella g result was non-reactive.In general, the customer performs duplicate testing of samples, and will report a result if they are the same.The non-reactive result from the reference laboratory was reported to the provided.Patient treatment was not prescribed or altered.There was no report of adverse health consequences due to the discordant rubella g result.
 
Manufacturer Narrative
Siemens filed the initial mdr 1219913-2017-00220 on 11/03/2017 for a false positive advia centaur cp rubella g (rub g) patient result.11/07/17 - additional information: a siemens customer service engineer (cse) returned to the customer site.The cse replaced the base sample dilutor, grey peri-pump, and checked precision that was acceptable.While there were multiple parts replaced by the cse while troubleshooting, the root cause is unknown.The instrument is performing within specifications.No further evaluation of the device is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR CP RUBELLA G (RUB G) ASSAY
Type of Device
RUBELLA G IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC
333 coney street
east walpole, MA 02032
Manufacturer Contact
stephen perry
333 coney street
east walpole, MA 02032
5086604163
MDR Report Key7001357
MDR Text Key91465043
Report Number1219913-2017-00220
Device Sequence Number1
Product Code LFX
UDI-Device Identifier00630414201412
UDI-Public00630414201412
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K003412
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 12/01/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/27/2018
Device Model NumberN/A
Device Catalogue Number10310283
Device Lot Number068196
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/13/2017
Initial Date FDA Received11/03/2017
Supplement Dates Manufacturer Received11/07/2017
Supplement Dates FDA Received12/01/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/27/2017
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-